Relaxed PSA Guidelines Might Miss Aggressive Tumors

Relaxed guidelines on prostate cancer screening may delay diagnosis and treatment of aggressive tumors, a new study suggests. In 2011, the U.S. Preventive Services Task Force recommended against routine prostate specific antigen testing, to curb over-diagnosis and overtreatment of prostate cancer.